The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data (RWD) with avelumab in patients (pts) with locally advanced or metastatic urothelial cancer (la-mUC): The AVEBLADDER study.
 
Marta Sotelo
No Relationships to Disclose
 
Mireia Pelaez
Speakers' Bureau - Bristol-Myers Squibb
 
Laura Basterretxea
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Ipsen; MSD
 
Estrella Varga
No Relationships to Disclose
 
Ricardo Sánchez-Escribano
No Relationships to Disclose
 
Eduardo Pujol
No Relationships to Disclose
 
Carmen Santander
Consulting or Advisory Role - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Merck
 
Mireia Martinez-Kareaga
Honoraria - Bristol-Myers Squibb; MSD; Roche
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Mikel Arruti Ibarbia
Travel, Accommodations, Expenses - Merck
 
Inma Rodríguez Ledesma
No Relationships to Disclose
 
Carlos Álvarez-Fernández
Consulting or Advisory Role - AstraZeneca; Bayer; Merck/Pfizer; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche
 
Pablo Piedra
No Relationships to Disclose
 
Veronica Calderero
No Relationships to Disclose
 
Nuria Lainez
No Relationships to Disclose
 
Juan Antonio Verdun Aguilar
No Relationships to Disclose
 
Irene Gil-Arnaiz
Honoraria - GSK, GILEAD
Expert Testimony - Roche
 
Ricardo Fernandez
No Relationships to Disclose
 
Cristina Mazas
No Relationships to Disclose
 
Ignacio Duran
Honoraria - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pfizer/EMD Serono; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer; Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Gilead Sciences; Ipsen; Pfizer/EMD Serono; Roche/Genentech